Business Overview: Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL)

---

Executive Summary

Kaival Brands Innovations Group, Inc. sells, markets, and distributes electronic nicotine delivery system ("ENDS") products — it does not manufacture what it sells. For years its business was almost entirely dependent on an exclusive worldwide distribution agreement for the BIDI® Stick, made by affiliate Bidi Vapor, LLC (owned by the KMDD Trust) through a China-based contract manufacturer.

The company matters today less as a steady distributor and more as a business in active transition: an International Trade Commission patent dispute and an FDA marketing denial order effectively halted Bidi Stick imports in 2024, shifting Kaival's primary revenue to royalties under an international license with Philip Morris Products S.A., while a pending merger with Delta Corp Holdings (announced September 2024) would leave existing Kaival shareholders with only about 10% of the combined company.

---

1. Core Business Model & How They Work

Kaival's historical model was pure distribution economics: buy finished vape products from its affiliated manufacturer-brand and resell through a wholesaler/retailer/sub-distributor network, without owning manufacturing or, for most of its history, significant intellectual property.

[ Bidi Vapor (Brand Owner) ] ➡️ [ China Contract Manufacturer ] ➡️ [ Kaival (Exclusive Distributor) ] ➡️ [ Wholesalers & Sub-Distributors ] ➡️ [ Retailers (QuikTrip, GPM, FAVS, etc.) ]

Key Operational Drivers

1. Single-supplier dependency: the company states its business "is dependent entirely on the resale of products provided by Bidi," with no alternative supplier relationship of similar scale.
2. Customer concentration: FY2024 sales were concentrated in QuikTrip (21%), GPM Investments (12%), and FAVS Business (11%).
3. Regulatory disruption: the FDA's January 2024 marketing denial order on the Classic BIDI® Stick and an RJ Reynolds-initiated ITC patent complaint cut off Bidi Stick imports, collapsing that revenue stream (Bidi product purchases fell from $12.8M in FY2023 to $0.3M in FY2024).
4. Pivot to royalties and licensing: Kaival's primary current revenue comes from royalties on an international license with Philip Morris Products S.A., alongside a dormant patent portfolio acquired from GoFire, Inc. in 2023 that management hopes to license.
5. Pending transformational merger: the September 2024 Merger Agreement with Delta Corp Holdings would fundamentally change the business, leaving legacy Kaival holders with a minority stake.

---

2. Key Offerings

---

3. Competitive Landscape

Kaival's historical competitive set is the U.S. disposable/closed-system vapor category, dominated by much larger players.

• Vuse (R.J. Reynolds/BAT): the single largest branded e-cigarette franchise in U.S. retail, and the same RJ Reynolds entity that brought the ITC patent complaint against the BIDI® Stick.
• NJOY, Juul, Logic: established closed-system and disposable brands with far greater marketing scale and, in several cases, FDA marketing authorizations Kaival/Bidi has not secured.
• Puff Bar and other disposable imports: lower-cost disposable competitors that have also faced FDA scrutiny, illustrating the regulatory risk common to the entire category.
• Kaival itself does not own the Bidi brand; its competitive position was always that of a distributor riding on Bidi's brand strength, not a brand owner competing directly.

---

4. Strategic Strengths & Risks

Competitive Strengths (The Moat)

• Established retail distribution relationships: a wholesaler/sub-distributor network and large retail accounts (QuikTrip, GPM Investments) built over several years.
• Philip Morris licensing relationship: a tie to a major global tobacco company provides a revenue bridge while the Bidi Stick business is disrupted.

Strategic Risks & Vulnerabilities

1. Total supplier dependency: with Bidi Stick imports halted and no equivalent alternative supplier, Kaival's legacy revenue model is effectively broken.
2. Regulatory exposure: the FDA marketing denial order and the ITC consent order against Bidi directly caused the collapse in Bidi product revenue, and similar actions could affect future products.
3. Going-concern risk: the FY2024 10-K's risk factors state the company has "a present need for additional funding, which raises questions about our ability to continue as a going concern."
4. Merger uncertainty: the pending Delta Corp Holdings merger is not assured to close, and if it does, legacy Kaival shareholders would hold only a small minority stake, diluting their exposure to any recovery.
5. Customer concentration: the top three retail customers represented ~44% of FY2024 revenue, concentrating counterparty risk.

---

5. Financial Overview

---

6. Summary Conclusion

Kaival Brands' story has effectively inverted: a company built entirely on exclusive distribution rights to the BIDI® Stick now earns its keep mostly from Philip Morris licensing royalties after regulatory and patent actions halted its core import-and-resell business. Any moat it once had was borrowed from Bidi's brand and retail relationships rather than owned outright, and that borrowed advantage has now largely evaporated. The biggest forward risk is binary: whether the pending Delta Corp Holdings merger closes on terms that preserve any value for legacy shareholders, since the standalone distribution business that once generated the bulk of revenue no longer meaningfully exists.